Section: Clinical Methods & Interventions

Veterinary Anthelmintic Administration Protocols and Resistance Management in Ruminants

Introduction

Anthelmintic resistance in ruminant livestock represents one of the most significant threats to sustainable grazing animal production globally. The primary nematode and trematode pathogens affecting sheep, goats, and cattle include species such as Haemonchus contortus, Teladorsagia circumcincta, Trichostrongylus colubriformis, Cooperia oncophora, and the liver fluke Fasciola hepatica. Resistance has been documented to all major anthelmintic classes, including the benzimidazoles (BZ), macrocyclic lactones (ML), imidazothiazoles (e.g., levamisole), and the salicylanilide triclabendazole. This article provides a detailed examination of administration protocols, the fecal egg count reduction test (FECRT) as a diagnostic tool, and the principles of refugia-based management.

Anthelmintic Administration Routes

Three primary routes of anthelmintic administration are used in ruminants: oral drenching, parenteral injection, and topical pour-on application. Each route has distinct pharmacokinetic properties, bioavailability profiles, and implications for resistance selection.

Oral Drenching

Oral drenching involves the direct administration of a liquid formulation into the oral cavity, typically targeting the esophageal groove to ensure passage into the rumen or abomasum. Drench formulations are available for benzimidazoles (e.g., albendazole, fenbendazole, oxfendazole), levamisole, and some macrocyclic lactones (e.g., ivermectin oral drench). The key advantage of oral drenching is the ability to deliver a precise dose based on body weight, minimizing underdosing. However, drenching requires proper technique to avoid spillage or aspiration. The esophageal groove reflex in sheep and cattle directs liquid into the abomasum, bypassing the rumen, which can alter drug absorption for certain compounds.

Injectable Formulations

Injectable anthelmintics are primarily macrocyclic lactones (e.g., ivermectin, doramectin, moxidectin) administered subcutaneously or intramuscularly. Injection provides systemic distribution and is particularly effective against ectoparasites and endoparasites with tissue-dwelling stages. The pharmacokinetics of injectable MLs result in prolonged drug exposure, which can increase selection pressure for resistance. Subcutaneous injection in the neck or behind the shoulder is standard. The use of injectable formulations in cattle is common for the control of Cooperia oncophora and Dictyocaulus viviparus. In sheep, injectable MLs are used for Haemonchus contortus and Teladorsagia circumcincta control.

Pour-On Formulations

Pour-on anthelmintics are applied topically along the dorsal midline of the back. They are lipophilic and absorbed transdermally, providing systemic activity. Pour-on MLs (e.g., ivermectin, eprinomectin) are widely used in cattle. The bioavailability of pour-on products can be affected by coat condition, rain, and licking behavior. Pour-on administration is less labor-intensive but carries a higher risk of underdosing due to variable absorption. Resistance to pour-on MLs has been documented, particularly in Cooperia oncophora.

Administration Protocol Table

Route Drug Class Typical Species Key Pharmacokinetic Feature Resistance Risk Factor
Oral Drench BZ, Levamisole, ML Sheep, Goats Esophageal groove bypass Underdosing if technique poor
Injectable ML (Ivermectin, Moxidectin) Cattle, Sheep Prolonged tissue half-life Persistent drug exposure
Pour-On ML (Eprinomectin, Ivermectin) Cattle Transdermal absorption Variable bioavailability

Fecal Egg Count Reduction Test (FECRT)

The FECRT is the standard method for detecting anthelmintic resistance in nematode populations of ruminants. It compares fecal egg counts (FEC) before and after treatment. The World Association for the Advancement of Veterinary Parasitology (WAAVP) guidelines specify that a reduction of less than 95% in mean FEC, with a lower 95% confidence interval below 90%, indicates resistance for benzimidazoles and levamisole. For macrocyclic lactones, the threshold is a reduction less than 99% with a lower confidence interval below 95%.

FECRT Calculation

The FECRT is calculated using the formula:

FECRT (%) = 100 x (1 - (T2 / T1))

Where T1 is the mean FEC before treatment and T2 is the mean FEC after treatment (typically 10-14 days for BZ and levamisole, 14-21 days for ML). A modified FECRT using arithmetic means and bootstrapping for confidence intervals is recommended.

Interpretation of FECRT Results

FECRT Value Interpretation Action
>95% Susceptible Continue use with monitoring
90-95% Suspect resistance Confirm with repeat testing
<90% Resistant Change drug class or implement refugia

Refugia Management

Refugia refers to the proportion of the parasite population not exposed to anthelmintic treatment. This population remains susceptible and dilutes the frequency of resistance alleles in subsequent generations. Refugia management is the cornerstone of resistance mitigation.

Strategies for Refugia

  1. Selective treatment of only high-risk animals: Treat only animals with FEC above a threshold (e.g., >200 eggs per gram). This leaves low-shedding animals untreated, maintaining a susceptible refugium.

  2. Targeted selective treatment (TST): Use clinical indicators such as FAMACHA score (anemia assessment for Haemonchus contortus), body condition score, or fecal egg count to identify animals requiring treatment.

  3. Delayed treatment of entire groups: Treating all animals at the same time eliminates the refugium. Leaving a portion of the herd untreated (e.g., 10-20%) preserves susceptible parasites.

  4. Pasture management: Rotational grazing with long rest periods can reduce larval contamination but may not select for resistance if combined with TST.

Refugia and Haemonchus contortus

Haemonchus contortus, the barber pole worm, is a highly fecund blood-feeding nematode of sheep and goats. Its rapid life cycle (3 weeks) and high egg output make it a primary target for resistance selection. Refugia management is critical for this species. The FAMACHA system, which scores conjunctival pallor on a 1-5 scale, allows selective treatment of anemic animals. This approach reduces treatment frequency and preserves susceptible refugia.

Refugia and Teladorsagia circumcincta

Teladorsagia circumcincta is an abomasal nematode of sheep in temperate regions. It causes reduced feed intake and weight loss. Resistance to MLs is widespread. Refugia management for T. circumcincta involves treating only lambs with high FEC and leaving adult ewes untreated, as adults often carry lower burdens and contribute to refugia.

Refugia and Fasciola hepatica

Fasciola hepatica, the liver fluke, is a trematode with a complex life cycle involving aquatic snail intermediate hosts. Resistance to triclabendazole has been reported. Refugia for fluke involves treating only animals with confirmed infection (via coproantigen ELISA or pooled PCR) and avoiding blanket treatment of all grazing animals. The use of flukicides with different modes of action (e.g., clorsulon, nitroxynil) in rotation can reduce resistance selection.

Resistance Mechanisms

Benzimidazole Resistance

Benzimidazole resistance is caused by mutations in the beta-tubulin gene (codon 200, 167, 198). These mutations reduce drug binding to tubulin, preventing microtubule disruption. Resistance is detected by allele-specific PCR or pyrosequencing.

Macrocyclic Lactone Resistance

Macrocyclic lactone resistance involves mutations in glutamate-gated chloride channels and P-glycoprotein efflux pumps. Resistance is polygenic and less well characterized at the molecular level. Phenotypic detection via FECRT is standard.

Levamisole Resistance

Levamisole resistance is associated with mutations in nicotinic acetylcholine receptors. It is less common than BZ or ML resistance but has been reported in Teladorsagia circumcincta.

Integrated Control Strategies

Drug Rotation

Rotation between drug classes on an annual or seasonal basis can reduce resistance selection. However, rotation must be based on FECRT results. Using two drugs from the same class (e.g., ivermectin and moxidectin) is not rotation.

Combination Therapy

Combining two anthelmintics with different modes of action (e.g., BZ + levamisole) can increase efficacy against resistant populations. Combination therapy is used in some regions but requires careful monitoring.

Pasture Hygiene

Reducing larval contamination through pasture rest, haymaking, or grazing with non-ruminant species (e.g., horses, poultry) can lower the parasite burden and reduce treatment frequency.

Diagnostic Tools

Fecal Egg Count (FEC)

FEC using the McMaster method or modified Wisconsin method provides quantitative data. The sensitivity of McMaster is 50 eggs per gram (epg). For low-level infections, the FLOTAC method (sensitivity 1 epg) is superior.

Coproantigen ELISA

For Fasciola hepatica, coproantigen ELISA detects fluke antigens in feces. It is more sensitive than FEC for fluke and can detect early infection.

Pooled PCR

Pooled PCR for nematode species identification uses species-specific primers for ITS-2 rDNA. It can detect resistance alleles in pooled samples.

Mermaid Diagram: Anthelmintic Resistance Management Decision Tree

graph TD
    A[FECRT Results], > B{Reduction >95%?}
    B, >|Yes| C[Continue current protocol]
    B, >|No| D{Reduction 90-95%?}
    D, >|Yes| E[Confirm with repeat FECRT]
    D, >|No| F[Resistance confirmed]
    F, > G[Change drug class]
    G, > H[Implement refugia]
    H, > I[Selective treatment based on FEC]
    I, > J[Monitor with FECRT annually]
    J, > A

Conclusion

Anthelmintic resistance in ruminants is a complex, multifactorial problem requiring integrated management. Administration protocols must be precise, with accurate dosing and appropriate route selection. The FECRT is the gold standard for resistance detection. Refugia management, through selective treatment and pasture hygiene, preserves susceptible parasite populations. Continued research into molecular resistance mechanisms and novel anthelmintics is essential for sustainable control.

References

  1. Coles GC, Jackson F, Pomroy WE, et al. The detection of anthelmintic resistance in nematodes of veterinary importance. Veterinary Parasitology. 2006;136(3-4):167-185.
  2. Kaplan RM. Drug resistance in nematodes of veterinary importance: a status report. Trends in Parasitology. 2004;20(10):477-481.
  3. Sangster NC. Pharmacology of anthelmintic resistance in parasites. International Journal for Parasitology. 1999;29(1):115-124.
  4. Wolstenholme AJ, Fairweather I, Prichard RK, et al. Drug resistance in veterinary helminths. Trends in Parasitology. 2004;20(10):469-476.
  5. Van Wyk JA, Bath GF. The FAMACHA system for managing haemonchosis in sheep by clinically identifying individual animals for treatment. Veterinary Research. 2002;33(5):509-529.
  6. Sargison ND. Sheep flock health: a planned approach. Blackwell Publishing. 2008.
  7. Taylor MA, Coop RL, Wall RL. Veterinary Parasitology. 4th ed. Wiley-Blackwell. 2016.
  8. Prichard RK. Genetic variability and selection for resistance to anthelmintics. International Journal for Parasitology. 1990;20(4):515-521.
  9. Gilleard JS, Beech RN. Population genetics of anthelmintic resistance in parasitic nematodes. Parasitology. 2007;134(8):1133-1147.
  10. Leathwick DM, Waghorn TS, Miller CM, et al. Managing anthelmintic resistance: is it feasible to use a combination of drugs? New Zealand Veterinary Journal. 2009;57(4):204-210.